Reduced risk of acute GVHD following mobilization of HLA-identical sibling donors with GM-CSF alone

S. M. Devine, R. A. Brown, V. Mathews, K. Trinkaus, H. Khoury, D. Adkins, R. Vij, D. Sempek, T. Graubert, M. Tomasson, L. T. Goodnough, J. F. DiPersio

Research output: Contribution to journalReview articlepeer-review

24 Scopus citations


We retrospectively reviewed the results of transplanting peripheral blood progenitor cell (PBPC) allografts from HLA-matched sibling donors mobilized using various hematopoietic cytokines. Patients had received allografts mobilized with Granulocyte colony-stimulating factor (G-CSF) (G, N=65) alone, G plus Granulocyte-macrophage colony stimulating factor (GM-CSF) (G/GM, N=70), or GM-CSF alone at 10 or 15μg/kg/day (GM, N =10 at 10μg/kg/day and 21 at 15μg/kg/day). The CD34+ and CD3+ cell content of grafts were significantly lower following GM alone compared to G alone (P<0.001 and 0.04, respectively). Nonhematopoietic toxicity observed in donors precluded dose escalation of GM-CSF beyond 10μg/kg/day. Hematopoietic recovery was similar among all three groups. Grades II-IV acute graft-versus-host disease (GVHD) was observed in only 13% of patients in the GM alone group compared to 49 and 69% in the G alone or G/GM groups, respectively (P<0.001). In a multivariate analysis, receipt of PBPC mobilized with GM alone was associated with a lower risk of grades II -IV acute GVHD (hazard ratio 0.21; 95% CI 0.073, 0.58) compared to G alone or G/GM. There were no differences in relapse risk or overall survival among the groups. Donor PBPC grafts mobilized with GM-CSF alone result in prompt hematopoietic engraftment despite lower CD34+ cell doses and may reduce the risk of grades II-IV acute GVHD following HLA-matched PBPC transplantation.

Original languageEnglish
Pages (from-to)531-538
Number of pages8
JournalBone Marrow Transplantation
Issue number6
StatePublished - Sep 2005


  • Allogeneic
  • Donor
  • G-CSF
  • GM-CSF
  • GVHD
  • Mobilizaton


Dive into the research topics of 'Reduced risk of acute GVHD following mobilization of HLA-identical sibling donors with GM-CSF alone'. Together they form a unique fingerprint.

Cite this